Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Centocor submits sBLA to FDA for Remicade as treatment of rheumatoid arthritis

Oct. 21, 1999

Expanded agreement between Vertex and HMR receives Hart-Scott-Rodino clearance

Oct. 21, 1999

Dimethaid granted license for Pennsaid Topical Lotion in the U.K.

Oct. 19, 1999

Selective inhibitors of alpha4 integrins designed at Celltech as cell adhesion modulators

Oct. 19, 1999

American Cyanamid claims nonpeptide MMP/TACE inhibitors for wide range of indications

Oct. 18, 1999

Novel caspase-1 inhibitors designed at Vertex

Oct. 15, 1999

Anti-PECAM-1 antisense compounds for inflammation, cell hyperproliferation designed at Isis

Oct. 15, 1999

Celgene discovers new class of compounds inhibiting inflammatory cytokine production

Oct. 14, 1999

Apotex describes new inhibitors of cysteine proteases in recent patent literature

Oct. 8, 1999

New MMP inhibitors from Leo reportedly superior to structurally related compounds

Oct. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...